-transparent.png){kind=logo}
BACKGROUND The association between Hepatitis B virus infection and membranous nephropathy has been confirmed by sources in several countries. Most commonly, the illness is seen as a nephrotic syndrome. Optimal treatment remains undefined. Antiviral therapies observed with recombinant human interferon alpha may be the best treatment option. METHODS We present a 7-year old boy with membranous glomerulonephritis and nephrotic syndrome. Twelve months after the initial hospitalization therapy was started with recombinant alpha-interferon s.c. three times weekly for six months. After the therapy the patient is stable, without proteinuria, edema or renal failure. He was seronegative for HBsAg, HBV-DNA and antibody to HBeAg. CONCLUSIONS This case report suggests that alpha interferon is effective in the complete resolution of proteinuria in HBV membranous nephropathy.
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
November 1991,
The Journal of pediatrics,
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
July 1983,
Archives of disease in childhood,
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
June 1993,
Pediatric nephrology (Berlin, Germany),
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
August 1995,
Pediatric nephrology (Berlin, Germany),
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
September 1992,
Pediatric nephrology (Berlin, Germany),
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
January 1995,
Kidney international,
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
January 1985,
Hepatology (Baltimore, Md.),
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
January 1997,
American journal of nephrology,
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
January 1985,
Clinical nephrology,
J O Steiss, and
K Piske-Keyser, and
H J Gröne, and
L Gortner
December 1979,
American journal of clinical pathology,
